Oral 5‐aminosalicylic acid for maintenance of remission in ulcerative colitis

Review (44 studies, n=9967) states there is high‐certainty evidence that 5‐aminosalicylic acid (5‐ASA) is superior to placebo for maintenance therapy in ulcerative colitis; and there is high‐certainty evidence that 5‐ASA is inferior compared to sulfasalazine.

Source:

Cochrane Database of Systematic Reviews